Ginsenosides have been shown to alter synaptic plasticity and the cholinergic system, reduce A exacerbation and tau hyperphosphorylation, and have anti-neuroinflammatory, antioxidant, and anti-apoptotic properties in the treatment of dementia, among other things, by Wang et al. (36). This evidence concerns the gene MAPT and dementia.